ОТНОСТНО ТОЗИ ЕПИЗОД
Professor Francesco Del Galdo and Professor Yannick Allanore discuss two recent studies advancing the treatment landscape in scleroderma. This episode discusses tofacitinib efficacy and neutrophil-driven vasculopathy in SSc. Through expert-led discussion, this podcast offers practical perspectives for clinicians looking to stay at the forefront of scleroderma care.
To explore the full papers and download accompanying slide decks, visit the Scleroderma Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: www.scleroderma-forum.com
To explore the full papers and download accompanying slide decks, visit the Scleroderma Forum. Stay up to date with the latest research and monthly podcast episodes through this free independent resource: www.scleroderma-forum.com
Английски
САЩ
ТРАНСКРИПЦИЯ 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
ТЪРСЕНЕ на МИНАЛИ ЕПИЗОДИ
Търсене в минали епизоди на Scleroderma Forum.
ДРУГИ ЕПИЗОДИ В ТОЗИ ПОДКАСТ
Join Professors Francesco Del Galdo and Zsuzsanna McMahan as they review their highlights of the recent ACR 2025 congress, watch them discuss their abstracts and highlight key information.
Join Professors Francesco Del Galdo and Elisabetta Renzoni, Doctor Elizabeth Volkmann and Clinical Nurse Specialist Jean Scopes as they discuss the key takeaways from our recent 'Harnessing the Power of the Multidisciplinary Team in Scleroderma' webinar.
Join Professors Francesco Del Galdo from the University of Leeds, and Chris Denton from UCL, as they discuss the role of autoantibodies in scleroderma.
Join Professors Francesco Del Galdo, Christopher Denton and Yannick Allanore as they discuss the key takeaways from our recent 'The Role of Autoantibodies in SSc' webinar.
Опровержение: Подкастът и произведенията на изкуството, вградени на тази страница, са от Scleroderma Forum, което е собственост на неговия собственик и не е свързано с или одобрено от Listen Notes, Inc.
РЕДАКТИРАНЕ
Благодарим Ви, че помогате да поддържаме базата данни за подкастове актуална.
